Critical Issues in Oral Vaccine Development
Edit Page
Report
Scan day: 06 February 2014 UTC
70
Virus safety - good
Description: Discussion about crossregulatory networks that control how an immune response develops after oral vaccination.
Peripheral and Mucosal Immunity after Oral Vaccination Peripheral and Mucosal Immunity: Critical Issues for Oral Vaccine Design Promising new technologies from recombinant DNA and biodegradable polymer research will change how vaccines are produced and used (Michalek et al., 1995; Walker, 1994; Anderson, 1997). Two recent papers entitled, "Generation and Assembly of Secretory Antibodies in Plants" (Ma et al., 1995) and "Oral Immunization with a Recombinant Bacterial Antigen Produced in Transgenic Plants" (Haq et al., 1995) demonstrated that large-scale agricultural production of recombinant vaccine antigens and functional recombinant human antibodies is feasible and can yield quantities of product sufficient to satisfy virtually any requirement, including "edible" vaccines.
Size: 814 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | Peripheral and Mucosal Immunity after Oral Vaccination |
| Keywords: | mucosal immunity, immunology, oral vaccines, edible vaccines, needleless vaccines, mucosal adjuvant, microencapsulation, postdoctoral fellowships, cross regulation, immune deviation, Th1, Th2, cytokines, biotechnology, recombinant vaccines, plant vaccines, usamriid, fort detrick |
| Description: | |
| IP-address: | 98.136.187.13 |
WHOIS Info
| NS | Name Server: YNS1.YAHOO.COM Name Server: YNS2.YAHOO.COM |
| WHOIS | Status: clientTransferProhibited |
| Date | Created by Registrar: Melbourne IT Ltd Last Updated by Registrar: Melbourne IT Ltd Last Updated Date: Sun Oct 20 09:48:43 GMT 2013 Expiration Date: Sun Oct 26 23:59:59 GMT 2014 |